Abstract

Increasing antibiotic resistance and ever stricter control on antibiotic use are a driving force to develop alternatives to antibiotics. One such strategy is the use of multifunctional Host Defense Peptides. Here we examined the protective effect of prophylactic treatment with the D analog of chicken cathelicidin-2 (D-CATH-2) against a respiratory E. coli infection. Chickens were treated with D-CATH-2 in ovo at day 18 of embryonic development or intramuscularly at days 1 and 4 after hatch. At 7 days of age, birds were challenged intratracheally with avian pathogenic E. coli. Protection was evaluated by recording mortality, morbidity (Mean Lesion Score) and bacterial swabs of air sacs at 7 days post-infection. In ovo D-CATH-2 treatment significantly reduced morbidity (63%) and respiratory bacterial load (>90%), while intramuscular treatment was less effective. D-CATH-2 increased the percentage of peripheral blood lymphocytes and heterophils by both administration routes. E. coli specific IgM levels were lower in in ovo treated animals compared to intramuscular D-CATH-2 treatment. In short, in ovo treatment with the Host Defense Peptide derived D-CATH-2 can partially protect chickens from E. coli infection, making this peptide an interesting starting point to develop alternatives to antibiotics for use in the poultry sector.

Highlights

  • Increasing antibiotic resistance and ever stricter control on antibiotic use are a driving force to develop alternatives to antibiotics

  • While in some species this class of Host Defense Peptides (HDPs) is represented by a single molecule (LL-37 in humans, CRAMP in mice), a wider repertoire of cathelicidins is found in other animals with the pig genome encoding for eleven of these peptides[1]

  • In this article we evaluate the prophylactic anti-infective efficacy of the D-amino acid analog of CATH-2 in young broiler chickens infected with avian pathogenic E. coli

Read more

Summary

Introduction

Increasing antibiotic resistance and ever stricter control on antibiotic use are a driving force to develop alternatives to antibiotics One such strategy is the use of multifunctional Host Defense Peptides. We examined the protective effect of prophylactic treatment with the D analog of chicken cathelicidin-2 (D-CATH-2) against a respiratory E. coli infection. In ovo treatment with the Host Defense Peptide derived D-CATH-2 can partially protect chickens from E. coli infection, making this peptide an interesting starting point to develop alternatives to antibiotics for use in the poultry sector. Antibiotic resistance is a large and growing problem in both veterinary and human medicine This has caused an intense search for alternative means to prevent and fight infections. Chicken cathelicidin-2 (CATH-2) has previously shown multiple immunomodulatory effects including inhibition of LPS-induced effects and induction of chemokines[13,14]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call